Intra-Cellular Therapies Inc. buy Cantor Fitzgerald
Start price
23.02.24
/
50%
€64.80
Target price
23.02.25
€93.28
Performance (%)
5.71%
Price
11:17
€68.50
Summary
This prediction is currently active. With a performance of 5.71%, the BUY prediction by Cantor_Fitzgerald for Intra-Cellular Therapies Inc. is trending in the right direction. This prediction currently runs until 23.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intra-Cellular Therapies Inc. | -1.460% | -1.460% |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $101.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
24.04.24
24.04.24
€112.30
24.04.25
24.04.25
0.00%
11:17
11:17
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€59.40
14.12.23
14.12.23
€91.89
14.12.24
14.12.24
15.32%
11:17
11:17
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€51.30
03.11.23
03.11.23
€94.07
03.11.24
03.11.24
31.58%
11:17
11:17
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€80.23
29.03.24
29.03.24
22.14%
30.03.24
30.03.24